Follow
Aditi Dhir
Aditi Dhir
Pediatric Hematology Oncology , University of Miami Miller school of Medicine
Verified email at med.miami.edu
Title
Cited by
Cited by
Year
Lumbar spinal atypical teratoid rhabdoid tumor
A Dhir, T Tekautz, V Recinos, E Murphy, RA Prayson, P Ruggieri, J Wolff
Journal of Clinical Neuroscience 22 (12), 1988-1989, 2015
152015
Parameters of metabolic syndrome in Indian children with epilepsy on valproate or phenytoin monotherapy
A Dhir, S Sharma, P Jain, BK Bhakhri, S Aneja
Journal of pediatric neurosciences 10 (3), 222-226, 2015
102015
Central venous line associated deep vein thrombosis in hospitalized children
A Dhir, S DeMarsh, A Ramgopal, S Worley, M Auron, V Hupertz, ...
Journal of pediatric hematology/oncology 41 (7), e432-e437, 2019
92019
Impact of sociodemographic factors on early mortality in acute promyelocytic leukemia in the United States: A time‐trend analysis
OH Jamy, A Dhir, LJ Costa, AC Xavier
Cancer 128 (2), 292-298, 2022
82022
PTCT-01 Intercontinental multidisciplinary data collection and treatment optimization study for patients with choroid plexus tumors
M Bahar, A Dhir, U Kordes, J Wolff
Neuro-oncology 17 (suppl_5), v186-v186, 2015
72015
Role of Precision Medicine in Pediatric Oncology
C Cahaney, A Dhir, T Ghosh
Pediatric annals 51 (1), e8-e14, 2022
52022
Impact of insurance status on the survival of younger patients diagnosed with acute promyelocytic leukemia in the United States
OH Jamy, R Godby, A Dhir, LJ Costa, AC Xavier
Cancer 127 (16), 2966-2973, 2021
52021
Osteogenic sarcoma of the head and neck: Is chemotherapy needed?
S Bialick, L Campoverde, JAO Gallegos, P Barreto-Coelho, A Watson, ...
Current treatment options in oncology 24 (5), 528-541, 2023
42023
An epigenetic screen identifies PRMT5 as a target for inhibition of FLT3-ITD AML cell growth in combination with tyrosine kinase inhibitors
A Dhir, AJ Paterson, S Qiu, AK Mullen, NR Anderson, R Bhatia
Blood 134, 2524, 2019
32019
KIT resistance mutations identified by circulating tumor DNA and treatment outcomes in advanced gastrointestinal stromal tumor.
S Bialick, BE Rose, AP Espejo-Freire, P Barreto Coelho, PA Costa, ...
Journal of Clinical Oncology 40 (16_suppl), 11514-11514, 2022
22022
Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma.
A Dhir, T Koru-Sengul, J Grosso, GZ D'Amato, MM Trucco, A Rosenberg, ...
Journal of Clinical Oncology 39 (15_suppl), 11542-11542, 2021
22021
Recurrent Skin Langerhan Cell Histiocytosis Successfully Treated With Indomethacin Monotherapy
A Dhir, DR Kelly, RG Watts, MA Kutny
Journal of pediatric hematology/oncology 42 (8), e795-e797, 2020
22020
Paraneoplastic cerebellar degeneration in diffuse large B-cell lymphoma and review of associated onconeural antibodies
V Saini, A Dhir, AW Rudnick, J Lukas, KJ Lizarraga, J Margolesky, ...
Clinical Lymphoma Myeloma and Leukemia 20 (6), e336-e340, 2020
22020
Simultaneous osteosarcoma and renal cell carcinoma with BRCA1 mutation in a young male adult with prior oligodendroglioma
A Dhir, R Li, G Li, J Dean, NH Robin, E Alva
Pediatric blood & cancer 67 (3), e28116-n/a, 2020
22020
Metabolic syndrome in children with epilepsy on valproate and phenytoin monotherapy: A cross-sectional study
A Dhir, S Sharma, S Aneja
Journal of the Neurological Sciences 333, e29, 2013
22013
Retrospective Application of Sinusoidal Obstruction Syndrome/Veno-occlusive Disease Diagnostic Criteria in a Pediatric Hematopoietic Stem Cell Transplant Cohort
A Dhir, A Wadhwa, H Haines, J Chewning, S Murthy, J Kim, L Beatty, ...
Journal of pediatric hematology/oncology 44 (2), e343-e348, 2022
12022
Pralatrexate‐based therapy induced response in an adolescent with refractory hepatosplenic T‐cell lymphoma
A Dhir, B Hill, ES Waite, MS Cairo, AC Xavier
Pediatric blood & cancer 67 (11), e28460, 2020
12020
Disparities in incidence and survival for patients with Ewing sarcoma in Florida
A Dhir, R Rahul, Q Liu, D Pham, R Kronenfeld, T Koru‐Sengul, ...
Cancer Medicine 13 (8), 2024
2024
DICER1-related Sertoli-Leydig cell tumor and rhabdomyosarcoma: An evolving disease with a challenging clinical course and treatment: A case report
N Shero, A Dhir, P Bejarano, S Rhode, JC Goicocechea
Case Reports in Women's Health 41, e00580, 2024
2024
Pan-sarcoma database (PSDB): A model-view-controller framework application utilizing REDCap, shiny, and R to create a continuous pipeline of sarcoma data that can inform the …
BE Rose, P Barreto Coelho, S Bialick, P Patel, K Statz-Geary, O Nunez, ...
JCO Oncology Practice 19 (11_suppl), 589-589, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20